E-LIB Suche - Ergebnisse für: Malladi, R

1

Prognostic factors for cellular therapies ‐ CART and alloge..:

Glass, B. ; Sureda, A. ; Boumendil, A....
Hematological Oncology. 41 (2023) S2 - p. 449-451 , 2023

2

Long‐term outcome of patients receiving haematopoietic allo..:

Gutiérrez‐García, G. ; Martínez, C. ; Boumendil, A....
British Journal of Haematology. 196 (2021) 4 - p. 1018-1030 , 2021

Link: https://doi.org/10.1111/..

3

PATIENT‐REPORTED QUALITY OF LIFE (QOL) FOLLOWING TISAGENLEC..:

Fowler, N. H. ; Dickinson, M. ; Martinez‐Lopez, J....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

4

Postremission Consolidation by Autologous Hematopoietic Cel..:

Passweg, J.R. ; Labopin, M. ; Christopeit, M....
Biology of Blood and Marrow Transplantation. 26 (2020) 4 - p. 659-664 , 2020

Link: https://doi.org/10.1016/..

5

Prolonged norovirus shedding and the use of a rapid norovir..:

Smith, C. ; Casey, A. ; Round, S.L....
Journal of Hospital Infection. 102 (2019) 3 - p. 354-355 , 2019

Link: https://doi.org/10.1016/..

6

NCRI PETREA TRIAL: A PHASE 3 EVALUATION OF PET‐GUIDED, RESP..:

Pettitt, A.R. ; Barrington, S. ; Kalakonda, N....
Hematological Oncology. 37 (2019) S2 - p. 67-68 , 2019

Link: https://doi.org/10.1002/..

7

U.K. national audit of extracorporeal photopheresis in cuta..:

Sanyal, S. ; Child, F. ; Alfred, A....
British Journal of Dermatology. 178 (2018) 2 - p. 569-570 , 2018

Link: https://doi.org/10.1111/..

8

Provision of cellular blood components to CMV‐seronegative ..:

Morton, S. ; Peniket, A. ; Malladi, R..
Transfusion Medicine. 27 (2017) 6 - p. 444-450 , 2017

Link: https://doi.org/10.1111/..

9

Treatment pathways and resource use associated with recurre..:

Radford, J ; McKay, P ; Malladi, R...
Bone Marrow Transplantation. 52 (2017) 3 - p. 452-454 , 2017

Link: https://doi.org/10.1038/..

10

BRENTUXIMAB VEDOTIN FOR RELAPSED HODGKIN LYMPHOMA AFTER ALL..:

Bazarbachi, A. ; Boumendil, A. ; Finel, H....
Hematological Oncology. 35 (2017) S2 - p. 83-84 , 2017

Link: https://doi.org/10.1002/..

11

YourTreatmentChoices: FAST ACCESS TO TRIALS PROGRAMME:

Radford, J. ; Gribben, J. ; Johnson, P.W....
Hematological Oncology. 35 (2017) S2 - p. 272-273 , 2017

Link: https://doi.org/10.1002/..

12

Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alon..:

Bento, L ; Boumendil, A ; Finel, H...
Bone Marrow Transplantation. 52 (2017) 8 - p. 1120-1125 , 2017

Link: https://doi.org/10.1038/..

13

Myeloablative versus reduced intensity allogeneic stem cell..:

Genadieva-Stavrik, S. ; Boumendil, A. ; Dreger, P....
Annals of Oncology. 27 (2016) 12 - p. 2251-2257 , 2016

Link: https://doi.org/10.1093/..

14

A Novel Approach to Isolating the Edge of the Shallow Trenc..:

Camillo-Castillo, Renata A. ; Liu, Qizhi Z. ; Jain, Vibhor...
ECS Transactions. 64 (2014) 6 - p. 53-63 , 2014

Link: https://doi.org/10.1149/..

15

Post-transplant T cell chimerism predicts graft versus host..:

Nikolousis, E. ; Robinson, S. ; Nagra, S....
Leukemia Research. 37 (2013) 5 - p. 561-565 , 2013

Link: https://doi.org/10.1016/..